NRX Pharmaceuticals, Inc.

Big Rock Partners Acquisition Corp. (Nasdaq: BRPA) was a blank-check company sponsored by Big Rock Partners that completed its initial public offering in 2018, targeting the healthcare and pharmaceutical sector. The company filed a 10-Q with the SEC on August 14, 2019, reflecting disclosures during its active search period. BRPA subsequently completed a business combination with NRX Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on treatments for neurological and pulmonary conditions, transitioning the shell entity into an operating company. The merger marked the conclusion of BRPA's lifecycle as a SPAC vehicle. For comprehensive filing history, deal timelines, and sponsor data on BRPA and hundreds of other SPACs, sign up for full access at SpacDesk.